EP 1420771 B9 20071017 - USE OF TRIFLUOROACETYL ALKYL-SUBSTITUTED PHENYL DERIVATIVES, PHENOL DERIVATIVES, AND BENZOYL DERIVATIVES IN THE TREATMENT AND/OR PROPHYLAXIS OF OBESITY AND ACCOMPANYING DISEASES AND/OR SECONDARY DISEASES
Title (en)
USE OF TRIFLUOROACETYL ALKYL-SUBSTITUTED PHENYL DERIVATIVES, PHENOL DERIVATIVES, AND BENZOYL DERIVATIVES IN THE TREATMENT AND/OR PROPHYLAXIS OF OBESITY AND ACCOMPANYING DISEASES AND/OR SECONDARY DISEASES
Title (de)
VERWENDUNG TRIFLUORACETYLALKYL-SUBSTITUIERTER PHENYL-, PHENOL- UND BENZOYLDERIVATE IN DER BEHANDLUNG UND/ODER PROPHYLAXE VON OBESITAS UND DEREN BEGLEIT- UND/ODER FOLGEERKRANKUNGEN
Title (fr)
UTILISATION DE DERIVES DE PHENYLE, DE PHENOL ET DE BENZOYLE SUBSTITUES PAR TRIFLUOROACETYLALKYLE DANS LE TRAITEMENT ET LA PROPHYLAXIE DE L'OBESITE DE SES MALADIES ASSOCIEES ET/OU SECONDAIRES ACCOMPAGNANT L'OBESITE
Publication
Application
Priority
- DE 10135027 A 20010718
- EP 0207782 W 20020712
Abstract (en)
[origin: US6930207B2] Novel and known trifluoroacetyl-substituted phenyl, phenol and benzoyl compounds for the treatment and/or inhibition of obesity and of concomitant and/or secondary diseases involved therewith, in particular metabolic syndrome and cardiovascular diseases. Novel trifluoroacetyl-substituted phenyl, phenol and benzoyl compounds, pharmaceutical preparations containing them and processes for the preparation of these compounds. Also compounds acting as inhibitors of lipase, in particular pancreatic lipase.
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/085 (2006.01); A61K 31/12 (2006.01); A61K 31/122 (2006.01); A61P 3/00 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 19/06 (2006.01); C07C 45/00 (2006.01); C07C 49/233 (2006.01); C07C 49/255 (2006.01); C07C 49/333 (2006.01); C07C 49/35 (2006.01); C07C 49/80 (2006.01); C07C 49/813 (2006.01); C07C 49/84 (2006.01)
CPC (source: EP US)
A61K 31/00 (2013.01 - EP US); A61K 31/12 (2013.01 - EP US); A61K 31/122 (2013.01 - EP US); A61P 3/00 (2018.01 - EP); A61P 3/04 (2018.01 - EP); A61P 3/06 (2018.01 - EP); A61P 3/10 (2018.01 - EP); A61P 9/00 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 9/12 (2018.01 - EP); A61P 19/06 (2018.01 - EP); A61P 31/00 (2018.01 - EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
WO 03007923 A2 20030130; WO 03007923 A3 20040108; AT E338542 T1 20060915; AU 2002328884 B2 20080207; AU 2002328884 B8 20080626; BR 0211196 A 20041026; CA 2455483 A1 20030130; CA 2455483 C 20120124; CN 1596106 A 20050316; CN 1596106 B 20110511; DE 10135027 A1 20030206; DE 50208081 D1 20061019; EP 1420771 A2 20040526; EP 1420771 B1 20060906; EP 1420771 B9 20071017; HK 1073245 A1 20050930; JP 2005500329 A 20050106; JP 4511172 B2 20100728; MX PA04000325 A 20050307; PL 216996 B1 20140630; PL 366933 A1 20050207; US 2004214901 A1 20041028; US 6930207 B2 20050816
DOCDB simple family (application)
EP 0207782 W 20020712; AT 02764680 T 20020712; AU 2002328884 A 20020712; BR 0211196 A 20020712; CA 2455483 A 20020712; CN 02814295 A 20020712; DE 10135027 A 20010718; DE 50208081 T 20020712; EP 02764680 A 20020712; HK 05105850 A 20050711; JP 2003513532 A 20020712; MX PA04000325 A 20020712; PL 36693302 A 20020712; US 75824004 A 20040116